Ads
related to: hepatitis a treatment and medication administration informationwiserlifestyles.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
Hepatitis A is an infectious disease of the liver caused by Hepatovirus A (HAV); [7] it is a type of viral hepatitis. [8] Many cases have few or no symptoms, especially in the young. [ 1 ] The time between infection and symptoms, in those who develop them, is two–six weeks. [ 2 ]
Hepatitis A vaccine is a vaccine that prevents hepatitis A. [ 2 ] [ 3 ] It is effective in around 95% of cases and lasts for at least twenty years and possibly a person's entire life. [ 4 ] If given, two doses are recommended beginning after the age of one. [ 2 ]
Combined hepatitis A and B vaccine, is used to provide protection against hepatitis A and hepatitis B. [3] [7] It is given by injection into muscle.[8]It is used in areas where hepatitis A and B are endemic, for travelers, people with hepatitis C or chronic liver disease, and those at high risk of sexually transmitted diseases.
There are eight treatment options approved by the U.S. Food and Drug Administration (FDA) available for persons with a chronic hepatitis B infection: alpha-interferon, pegylated interferon, adefovir, entecavir, telbivudine, lamivudine, tenofovir disoproxil and tenofovir alafenamide with a 65% rate of sustained response. [citation needed]
Drugs: People with hepatitis should avoid taking drugs metabolized by the liver. [17] Glucocorticoids are not recommended as a treatment option for acute viral hepatitis and may even cause harm, such as development of chronic hepatitis. [17] Precautions: Universal precautions should be observed. Isolation is usually not needed, except in cases ...
Hepatitis A and typhoid vaccine is a combination vaccine to protect against the infectious diseases hepatitis A and typhoid. It is a combination of inactivated Hepatitis A virus and Vi polysaccharide of Salmonella typhi bacteria.
President Donald Trump's executive orders have begun to disrupt patient care in the United States, as some providers cannot access essential federal funding, according to interviews with a dozen ...
Sofosbuvir/velpatasvir, sold under the brand name Epclusa among others, is a fixed-dose combination medication for the treatment of hepatitis C in adults. [2] [5] [6] [7] It combines sofosbuvir and velpatasvir. [2] [5] [6] It is more than 90% effective for hepatitis C genotypes one through six. [2]